Biopolym. Cell. 2020; 36(1):61-74.
Bioorganic Chemistry
2-(Dichloromethyl)pyrazolo[1,5-a][1,3,5]triazines: synthesis and anticancer activity
1Velihina Ye. S., 1Pil’o S. G., 1Zyabrev V. S., 1, 2Moskvina V. S., 1, 2Shablykina O. V., 1Brovarets V. S.
  1. V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine,
    1, Murmans'ka Str., Kyiv, Ukraine, 02094
  2. Taras Shevchenko National University of Kyiv
    64, Volodymyrska Str., Kyiv, Ukraine, 01601


Aim. Synthesis of a series of 2-(dichloromethyl)pyrazolo[1,5-a][1,3,5]triazines and evaluation in vitro of their anticancer activity against a panel of 60 cell lines derived from nine cancer types, namely leukemia, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer. Methods. Organic synthesis; biological tests; spectral methods; statistical methods. Results. In vitro screening of the anticancer activity showed that 5 of 26 tested compounds can effectively inhibit the growth of certain cancer cell lines. Conclusions. New type of N-(2,2-dichloro-1-cyanoethenyl)carboxamides heterocyclization with 1H-pyrazol-5-amines led to the formation of 2-(dichloromethyl)pyrazolo[1,5-a][1,3,5]triazines. Some of these compounds inhibit growth of certain cancer cell lines.
Keywords: in vitro screening, anticancer activity, heterocyclization, 1H-pyrazol-5-amines, pyra-zolo[1,5-a][1,3,5]triazines, 2-(dichloromethyl)pyrazolo[1,5-a][1,3,5]triazines.


[1] Schreiber SL. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 2000; 287(5460): 1964-9.
[2] Popowycz F, Fournet G, Schneider C, Bettayeb K, Ferandin Y, Lamigeon C, Tirado OM, Mateo-Lozano S, Notario V, Colas P, Bernard Ph, Meijer L, Joseph B. Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cycline-dependent kinase inhibitor (R)-roscovitine analogue. J Med Chem. 2009; 52(3): 655-63.
[3] He L, Gilligan PJ, Zaczek R, Fitzgerald LW, McElroy J, Shen HL, Saye JA, Kalin NH, Shelton S, Christ D, Trai-nor G, Hartig P. 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF1 receptor antagonist. J Med Chem. 2000; 43(3): 449-56.
[4] Nie Zh, Perreta C, Erickson Ph, Margosiak S, Almassy R, Lu J, Averill A, Yager K, Chu Sh. Structure-based de-sign, synthesis, and study of pyrazolo[1,5-a][1,3,5,]triazine derivatives as potent inhibitors of protein kinase CK2. Bioorg Med Chem Lett. 2007; 17(15): 4191-5.
[5] Nie Zh, Perreta C, Erickson Ph, Margosiak S, Lu J, Averill A, Almassy R, Chu Sh. Structure-based design and synthesis of novel pyrazolo[1,5-a][1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities. Bioorg Med Chem Lett. 2008; 18(2): 619-23.
[6] Ali Tel-S. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diohenyl-1,2,4-triazine moiety as potential antimicrobial agents. Eur J Med Chem. 2009; 44(11): 4385-92.
[7] Rooney CS, Williams HWR. Pyrazolo [1,5-a] [1,3,5] triazines. US Patent US3995039A. 1976.
[8] Popowycz F, Schneider C, Debonis S, Skoufias DA, Kozielski F, Galmarini CM, Joseph B. Synthesis and antipro-liferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives. Bioorg Med Chem. 2009; 17(9): 3471-8.
[9] Shaabani A, Nazeri MT, Afshari R. 5-Amino-pyrazoles: potent reagents in organic and medicinal synthesis. Mol Divers. 2019; 23: 751–807.
[10] Matsumura K, Saraie T, Hashimoto N. ββ-Dichloro-α-aminoacrylonitrile. J Chem Soc Chem Commun. 1972; 1(12): 705-6.
[11] Drach BS, Sviridov EP, Kisilenko AA, Kirsanov AV. Interaction of secondary amines with N-acyl-2,2-dichlorovinylamines and N-acyl-1-cyano-2,2-dichlorovinylamines. J Org Chem USSR. 1973; 9: 1842-6.
[12] Matsumura K, Saraie T, Hashimoto N. Studies of nitriles. VIII. Reactions of N-acyl derivatives of 2-amino-3,3-dichloroacrylonitrile (ADAN) with amines. 1. A new synthesis of 2-substituted-5-(substituted ami-no)oxazole-4-carbonitriles and 4-N-acylcarboxamides. Chem Pharm Bull. 1976; 24(5): 924-40.
[13] Chumachenko SA, Shablykin OV, Vasilenko AN, Brovarets VS. Synthesis and some properties of 5-alkylamino-2-(phthalimidoalkyl)-1,3-oxazole-4-carbonitriles. Chem Heterocycl Comp. 2011; 47(8): 1020-8.
[14] Abdurahmanova ER, Lukashuk EI, Golovchenko AV, Pil'o SG, Brovarets VS. N-Methyl-D-glucamine-Derived 4-Substituted 1,3-Oxazoles. Rus. J. Gen. Chem. (Engl. Transl.) 2015; 85(4): 851-7.
[15] Vinogradova TK, Mis'kevich GN, Drach BS. Reaction of functional derivatives of 3,3-dichloro-2-acylaminoacrylic acids with benzamidine. J Org Chem USSR. 1980; 16: 1587-92.
[16] Chumachenko SA, Shablykin OV, Kozachenko AP, Osadchuk TV, Brovarets VS. A new route for the synthesis of substituted 5-amino-4-cyanoimidazol-2-ones - precursors for the preparation of 3,6,7,9-tetrahydro-8H-purin-8-ones derivatives. Chem Heterocycl Comp. 2011; 47(3): 336-41.
[17] Kozachenko AP, Shablykin OV, Rusanov EB, Vasilenko AN, Brovarets VS. Transformation of the condensation products of 2-acylamino-3,3-dichloroacrylonitriles with imidazole into pyrazolo- [1,5-a]pyrimidine derivatives. Rus J Gen Chem. 2009; 79(5): 996-1000.
[18] Kozachenko AP, Shablykin OV, Chernega AN, Brovarets VS. Synthesis of a new heterocyclic system 7,8-dihydroimidazo[1,2-c][1,3]oxazolo[4,5-e]pyrimidine. Chem Heterocycl Comp. 2010; 46(9): 1116-21.
[19] Kozachenko AP, Shablykin OV, Vasilenko AN, Chernega AN, Brovarets VS. Synthesis and structure of a new heterocyclic system - 7,8-dihydroimida-zo[1,2-c][1,3]thiazolo[4,5-e]pyrimidine. Chem Heterocycl Comp. 2011; 47(4): 507-11.
[20] Kozachenko AP, Shablykin OV, Gakh AA, Rusanov EB, Brovarets VS. Synthesis of new heterocyclic system of 4,5,7,8-tetrahydroimidazo[1,2-c][1,3]thiazolo[4,5-e][1,3,2]diazaphosphinine starting from 2-aroylamino-3,3-dichloroacrylonitrile. Heteroatom Chem. 2010; 21(7): 492-8.
[21] Shablykin OV, Gakh AA, Brovarets VS, Rusanov EB, Drach BS. A Facile Synthesis of New 1,2-Dihydro-2λ5-[1,3]oxazolo[5,4-d][1,3,2]diazaphosphinine Derivatives Starting from 2-Benzoylamino-3,3-dichloroacrylonitrile. Heteroatom Chem. 2008; 19(5): 506511.
[22] Velihina YeS, Pil'o SG, Zyabrev VS, Brovarets VS. Synthesis and antiviral activity of 2-(dichloromethyl)pyrazolo[1,5-a][1,3,5]triazines. Dopov Nac akad nauk Ukr. 2019; (7): 75-80.
[23] Zyabrev VS, Babiy SB, Turov KV, Vasilenko OM, Vinogradova TK, Brovarets VS. 2,4-Disulfanyl-5-cycloamino substituted thiazoles and their using as anticancer drugs (in Ukrainian). Patent 109165 UA. 2015.
[24] Boyd MR, Paull KD. Some practical considerations and applications of the national cancer institute in vitro anti-cancer drug discovery screen. Drug Dev Res. 1995; 34: 91-109.
[25] Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003; 3: 330-8.